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Cardiovascular Images
MRI of Intimal Sarcoma of the Pulmonary Arteries
Pia K. Schuler, MD; Achim Weber, MD; Peter K. Bode, MD;
Michael Neuhaus, MD; Rene´ Preˆtre, MD; Rolf Jenni, MD, MSEE; Ju¨rg Schwitter, MD, FESC
A 38-year-old woman presented with left lower chestpain. At the age of 3 years, a commissurotomy of the
pulmonary valve and infundibulectomy was performed to
correct severe infundibular pulmonary stenosis. The initial
thoracic CT diagnosed bilateral pulmonary embolism.
Echocardiography revealed a filiforme mass in the pulmo-
nary artery 33 mm in length, floating in the right outflow
tract, suggesting a pulmonary sarcoma. In addition, a
moderate pulmonary valve insufficiency with mild stenosis
was diagnosed. Cardiac magnetic resonance (CMR) con-
firmed the mass in the left pulmonary artery (PA) with
floating parts and a small mass in the right PA (Figure 1)
and provided complementary findings identifying the mass
as tumor, differentiating it from chronic thromboembo-
lism. In particular, perfusion CMR1 demonstrated blood
flow in the mass (Figure 2A and 2B), and late contrast-
enhanced CMR revealed high- and low-signal territories in
the tumor suggesting heterogenous cell-rich and cell-
depleted components of the mass (Figure 3).2
Histology as shown in Figure 4 showed the mass to be an
intimal sarcoma with widespread vascularization with cell-
rich and myxoid, cell-depleted regions.
The patient underwent an open surgical resection of the
pulmonary mass including repair of the PA and pulmonary
valve replacement. An additional chemotherapy with adria-
mycin/Holoxan and uromitexan was started 4 months later,
and a lobectomy of the right upper pulmonary lobe was
performed for metastatic disease. One year after being diag-
nosed, the patient is still alive and has started working again.
The clinical presentation and radiological features may
mimic pulmonary embolism.3 The CMR criteria suggesting
tumor rather than emboli are (1) detectable tissue perfusion
and (2) heterogenous enhancement on late CMR imaging
resulting from differences in tumor cellularity.2
Intimal sarcoma is a rare, highly malignant neoplasm
that typically arises from the central pulmonary arteries.
The prognosis must be regarded as extremely poor. Most
patients die within months of right heart failure secondary
to outflow obstruction or distal (thrombo) embolism. The
main treatment for sarcoma is aggressive surgical resec-
tion, but, even after heart and lung transplantation, recur-
rent metastases in noncardiac organs occurred in half of
the patients. The role of adjuvant radiation and chemother-
apy remains unclear.3,4
CMR provides important information, readily distinguish-
ing tumors such as intimal sarcoma from thrombotic masses
in the pulmonary arteries, which are notoriously difficult to
discriminate with conventional diagnostic approaches.
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Figure 1. Mass in the left and right PA in axial (A) and sagittal
(B) views (steady-state free precession) are shown.
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Figure 2. Perfusion CMR shows signal increase during first pass of contrast medium through the mass at peak bolus (A) and repre-
sented as upslope map and signal-intensity–time curves (B).
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Figure 3. Late gadolinium-enhanced CMR identifies irregular
enhancement patterns in the tumor (the optimal TI was set to
null normal myocardium).
Figure 4. A, Vessel wall (upper part) with
polypoid tumor formations and adjacent
tumor necrosis and thrombotic material
(lower part) (hematoxylin and eosin staining;
scale bar, 2000 m). B, Myxoid area with
low cellular density and mitotic activity
(hematoxylin and eosin staining; scale bar,
100 m). C, Rhabdoid features (hematoxylin
and eosin staining; scale bar, 200 m). D,
CD34 immunostaining highlights numerous
small vascular clefts (scale bar, 100 m).
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